Navigation Links
Interferon Reduces, Eliminates Viral Infections in Heart Failure Patients
Date:11/11/2008

Study highlights:

- Interferon eliminated specific causes of some viruses in heart failure patients, improving their clinical outcomes.

- Treatment improved cardiac function and quality of life and showed no apparent safety concerns.

NEW ORLEANS, Nov. 11 /PRNewswire-USNewswire/ -- Giving interferon to heart failure patients with evidence of a chronic viral infection safely eliminated two viruses from their systems and reduced levels of a third virus. Additionally, there were trends toward improved cardiac function and quality of life, but these did not reach significance at 24 weeks, researchers reported at the American Heart Association's Scientific Sessions 2008. Results from the Effect of Subcutaneous Treatment with Interferon-Beta-1b over 24 weeks on Safety, Virus Elimination and Clinical Outcome in Patients with Chronic Viral Cardiomyopathy study were presented as a late-breaking clinical trial.

"These results from our randomized trial provide the first evidence that interferon beta-1b (IFNB-1b) treatment eliminates cardiotropic viruses and may improve the clinical outcomes of patients with chronic enteroviral and adenoviral heart disease," said Heinz Peter Schultheiss, M.D., the lead author of the study and a professor of medicine in the Department of Cardiology and Pneumology at Charite - University Medicine of Berlin, Campus Benjamin Franklin in Berlin, Germany.

The double-blind Phase II study included 143 patients at 31 medical centers in seven European countries.

Investigators also found a reduction in the viral load for parvovirus, but not evidence for elimination.

Researchers found that patients infected with adenovirus, enterovirus and/or parvovirus B19 who received IFNB-1b were about twice as likely to have improved symptoms 12 weeks after treatment ended. They found that 38.6 percent of the interferon patients had an improved New York Heart Association (NYHA) functional classification as compared
'/>"/>

SOURCE American Heart Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Study shows that high-dose, high-frequency interferon produces no additional benefit
2. GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
3. PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
4. Interferon does not slow or stop hepatitis C from worsening, study finds
5. For the First Time this Winter Consumers Have an Electronic Green Solution that Eliminates 99.97 Percent of Indoor Air Pollution
6. Ultra-High Pressure Processing Eliminates Salmonella in Fresh Tomatoes
7. Radian Guaranty Inc. Eliminates Stated Income and Stated Asset Programs
8. Verathon Inc. Introduces GlideScope(R) Ranger Single Use Video Laryngoscope for Emergency Departments, EMS and Military; Enables Fast Intubations and Eliminates Time-Consuming Disinfection
9. Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform
10. Doctor Recommends New Powerful Natural Antiviral Against the Flu
11. Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... HealthDay Reporter SATURDAY, Aug. ... an experimental drug was more effective than standard treatment ... According to the study authors, the trial was ... new drug, dubbed LCZ696. In the trial, ... (Vasotec), either died or were hospitalized due to heart ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 An operating ... a hospital for performing surgical operations. An operating room ... tables, surgical booms, operating room lights, imaging displays as ... a report by Transparency Market Research, a U.S.-based market ... to reach USD 4.5 billion by 2019. , ...
(Date:9/1/2014)... Barcelona, Spain Monday 1 September 2014: Daily fruit ... up to 40%, according to research presented at ESC ... The findings from the seven year follow-up study of ... found that the more fruit people ate, the more ... "CVD, including ischaemic heart disease (IHD) and stroke, is ...
(Date:9/1/2014)... York (PRWEB) September 01, 2014 ... retrieve, organize and analyze biological and genetic data. ... the activity of developing software tools to generate ... to be confused with biological computation. While bioinformatics ... understanding of biology can its related concepts, biological ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 Ontraport ... online marketers that was developed to automate the small ... the attention of Shane Michaels, prompting an investigative review. ... the daily duty of managing all of the small ... be quite overwhelming,” reports Michaels. “That’s why Ontraport has ...
Breaking Medicine News(10 mins):Health News:Drug Gives 'New Hope' Against Heart Failure, Expert Says 2Health News:Drug Gives 'New Hope' Against Heart Failure, Expert Says 3Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 3Health News:Fruit consumption cuts CVD risk by up to 40 percent 2Health News:Fruit consumption cuts CVD risk by up to 40 percent 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2
... researchers report , , WEDNESDAY, Oct. 31 (HealthDay News) -- Screening ... study suggests. , As a matter of fact, that might ... Dutch researchers who found that 7.2 percent of those who ... percent had cerebral aneurysms, and 1.6 had benign brain tumors. ...
... 31 The Medicare bidding,program for durable medical ... homecare infrastructure" unless Congress modifies,the program. This is ... a,congressional subcommittee today by the American Association for ... patients,standard of care, choice of provider, and access ...
... TSX, MONTREAL, Oct. 31 /PRNewswire-FirstCall/ - Haemacure ... of,its presentation at the Acumen BioFin Rodman & ... at 11:30 a.m. at the New York,Palace Hotel ... webcast the audio portion of the presentation and,post ...
... Mass., Oct. 31 Coley,Pharmaceutical Group, Inc. (Nasdaq: ... Ph.D., Coley,s President and Chief Executive Officer, plans ... Acumen BioFin Rodman &,Renshaw 9th Annual Healthcare Conference ... New York Palace Hotel. Interested parties may ...
... Tuesday, November 6 at 8:50 a.m. ET -, ... ) announced that William Iacona, Somanetics, chief financial,officer, will ... Annual,Healthcare Conference being held November 5-7, 2007 at the ... scheduled for 8:50 a.m. ET on,Tuesday, November 6, 2007, ...
... ... Information-, ... Breast Cancer Awareness Month, healthcare providers and advocacy,organizations now have ... educational, state-of-the-art Web site about,oral chemotherapy. This straightforward, credible site ...
Cached Medicine News:Health News:Brain MRIs Find Hidden Neurological Problems 2Health News:Brain MRIs Find Hidden Neurological Problems 3Health News:Medicare Bidding for Durable Medical Equipment Will Harm Small Businesses and Seniors' Access to Care, American Association for Homecare Testifies 2Health News:Medicare Bidding for Durable Medical Equipment Will Harm Small Businesses and Seniors' Access to Care, American Association for Homecare Testifies 3Health News:Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec 2Health News:Somanetics Corporation to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Health News:Roche Offers Innovative Website Designed to Empower Cancer Patients 2
(Date:8/29/2014)... -- In part four of a blog series ... a strategic asset, Mary Baxter, MBA, RPh ., ... Innovation Delivery Solutions business, discusses how expanding patient access ... patients. "Every hospital pharmacist knows that filling ... in a value-based healthcare world," Baxter says. "For the ...
(Date:8/29/2014)...  Pacific Medical Data Solutions is excited to announce ... The main website, along with the site,s blog, has ... and content relevant to the medical billing industry.   ... can now better understand how PMDS products help drive ... a more visible platform about medical billing best practices. ...
(Date:8/29/2014)... DUBLIN , August 29, 2014 ... management and collaboration software has announced a major new ... services, founded by renowned pathology expert, Dr. Marius ... advance of the 26th European Congress of Pathology which ... in the ExCeL Arena, London ...
Breaking Medicine Technology:Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4PMDS Announces New Website 2Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: